Bank of Hawaii raised its stake in Koninklijke Philips (NYSE:PHG – Free Report) by 61.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 38,122 shares of the technology company’s stock after buying an additional 14,542 shares during the quarter. Bank of Hawaii’s holdings in Koninklijke Philips were worth $700,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Perpetual Ltd purchased a new stake in shares of Koninklijke Philips during the first quarter worth $46,993,000. Fiduciary Management Inc. WI increased its position in Koninklijke Philips by 26.7% in the 4th quarter. Fiduciary Management Inc. WI now owns 8,687,852 shares of the technology company’s stock worth $130,231,000 after purchasing an additional 1,832,561 shares during the last quarter. BlackRock Inc. raised its stake in shares of Koninklijke Philips by 59.6% during the 1st quarter. BlackRock Inc. now owns 4,430,980 shares of the technology company’s stock worth $135,277,000 after purchasing an additional 1,655,150 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Koninklijke Philips by 3,812.0% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,636,961 shares of the technology company’s stock valued at $24,538,000 after buying an additional 1,595,116 shares during the last quarter. Finally, Mondrian Investment Partners LTD grew its stake in shares of Koninklijke Philips by 306.4% in the 4th quarter. Mondrian Investment Partners LTD now owns 1,944,063 shares of the technology company’s stock valued at $29,142,000 after buying an additional 1,465,665 shares in the last quarter. Hedge funds and other institutional investors own 6.58% of the company’s stock.

Get Koninklijke Philips alerts:

Analyst Upgrades and Downgrades

PHG has been the subject of a number of analyst reports. The Goldman Sachs Group began coverage on shares of Koninklijke Philips in a research note on Wednesday, July 12th. They issued a “buy” rating for the company. TheStreet raised shares of Koninklijke Philips from a “d+” rating to a “c-” rating in a research report on Monday, July 24th. Societe Generale raised Koninklijke Philips from a “sell” rating to a “hold” rating in a research report on Tuesday, April 25th. StockNews.com started coverage on Koninklijke Philips in a report on Thursday. They set a “buy” rating on the stock. Finally, Citigroup upped their target price on Koninklijke Philips to €19.00 ($20.65) in a research report on Friday, July 7th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Koninklijke Philips has a consensus rating of “Hold” and an average target price of $17.06.

Koninklijke Philips Trading Up 3.8 %

Shares of Koninklijke Philips stock opened at $22.20 on Friday. Koninklijke Philips has a 1 year low of $11.75 and a 1 year high of $23.30. The company’s fifty day simple moving average is $21.13 and its 200-day simple moving average is $19.32. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.69 and a current ratio of 1.20.

Koninklijke Philips (NYSE:PHG – Get Free Report) last posted its quarterly earnings data on Sunday, July 23rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.08. Koninklijke Philips had a negative net margin of 10.84% and a positive return on equity of 7.95%. The company had revenue of $4.87 billion for the quarter, compared to the consensus estimate of $4.30 billion. During the same quarter in the previous year, the firm posted $0.15 EPS. As a group, sell-side analysts expect that Koninklijke Philips will post 1.11 earnings per share for the current fiscal year.

About Koninklijke Philips

(Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.

Recommended Stories

Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.